ENDRA posts strong TAEUS Liver study data, showing high measurement reliability for MASLD monitoring and boosting its ...

CHICAGO--(BUSINESS WIRE)--A new study shows that a simple, non-invasive “contrast enhanced ultrasound” (CEUS) scan can be more accurate and reliable than a more expensive MRI procedure for diagnosis ...

The €5.4 million (40m DKK) investment for the MIRAQLE project supports the development of scalable clinically deployable hyperpolarised MRI for early liver cancer diagnostics. NVision, a quantum ...

As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become one of the most prevalent chronic liver conditions worldwide. Its progressive ...

The role of diagnostic imaging in the assessment of liver disease continues to gain in importance. The classic techniques used for liver imaging are ultrasonography, CT and MRI. In the past decade, ...

Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...

Magnetic Resonance Imaging (MRI) could offer a new non-invasive test for liver damage that could transform the care of patients with cirrhosis, say experts in Nottingham. In a paper published in the ...

MRI provides a safe, noninvasive way to monitor liver fat levels in people who undergo weight loss treatments for obesity, according to a new study. MRI provides a safe, noninvasive way to monitor ...

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Scientists have designed an imaging technique to detect early-stage liver tumors, and have proven it successful in mice. Their study in an animal model is an essential step toward creating tools to ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...